172@29@17@143!~!172@29@0@53!~!|news|business|wipro-has-no-layoff-plans-chairman-rishad-premji-5540761.html?utm_source=MC_OpeninApp!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsBusiness
Last Updated : Jul 13, 2020 01:31 PM IST | Source: Moneycontrol.com

Wipro has no layoff plans: Chairman Rishad Premji

The company employs about 1,82,886 employees and has employed work from home for more than 93 percent of them.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Wipro has no plans to layoff employees at the back of the pandemic, said Chairman Rishad Premji.

Speaking at the 74th annual general meeting, Premji said, “So far, not a single person has been laid off and (we) have no plans of laying off any employees.”

However, the company is driving cost cutting measures at the back of the pandemic, he added, responding to investor queries.

Close

The company employs about 1,82,886 employees and has employed work from home for more than 93 percent of them.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“We are looking (for a) balanced work from home approach and don’t expect 100 percent of the employees to work from (the) office,” he said. The company is evaluating options and seeing how the model unfolds in the next 12-18 months.

For the model to work in the long-term, the company would need client permissions. “We are also working with NASSCOM (IT industry body) on the same,” Premji said.

On the issue of H-1B, Premji said that, though the move was unfortunate, the company had de-risked itself by stepping up localisation.

“Right now, close to 70 percent of us employees in the US are locals,” he said.

Wipro’s H-1B dependence came down by close to 60 percent to 3,118 in FY19 from close to 7000 in FY16.

At the back of COVID-19, the company has seen accelerated adoption of technologies such as cloud and cybersecurity and is well-positioned to cater to the changing business models, Premji said.

Theirry Delaporte, who took charge as the CEO on July 6, said, that the primary focus will be on profitability and regaining momentum by making bold bets. “Over the next few weeks, working closely with Chairman Rishad Premji and other senior leaders, I hope to finalise the plan to drive improvements across all spheres in our quest to achieve industry-leading growth.”

Over the last few years the company’s growth has been stagnant, growing at 2 percent on average compared to its peers such as TCS, Infosys and HCL Tech. The company registered revenue of $8.256 billion for the year ended in March.
First Published on Jul 13, 2020 01:31 pm
Sections